Rick Maffei

Rick Maffei is the senior digital editor for Oncology Nurse Advisor.

All articles by Rick Maffei

[OncoTargets and Therapy] In this study, the efficacy of the chemotherapeutic regimen DCAG in patients aged 14 to 60 years with newly diagnosed AML was compared with standard therapy. Complete remission rate after the first cycle was comparable between the 2 regimens; but after the second cycle, a significant difference was observed.